TRANSCODE THERAPEUTICS Trademark

Trademark Overview

On Wednesday, October 20, 2021, a trademark application was filed for TRANSCODE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TRANSCODE THERAPEUTICS trademark a serial number of 97083236. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, May 16, 2024. This trademark is owned by TransCode Therapeutics, Inc.. The TRANSCODE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; diagnostic preparations for medical purposes
transcode therapeutics

General Information

Serial Number97083236
Word MarkTRANSCODE THERAPEUTICS
Filing DateWednesday, October 20, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, May 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer; diagnostic preparations for medical purposes
Pseudo MarkTRANS CODE THERAPEUTICS
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTransCode Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02109
Party NameTransCode Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02109

Trademark Events

Event DateEvent Description
Saturday, October 23, 2021NEW APPLICATION ENTERED
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 27, 2022ASSIGNED TO EXAMINER
Thursday, August 4, 2022NON-FINAL ACTION WRITTEN
Thursday, August 4, 2022NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, February 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 13, 2023SOU EXTENSION 1 FILED
Monday, November 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 16, 2024SOU EXTENSION 2 FILED
Thursday, May 16, 2024SOU TEAS EXTENSION RECEIVED
Thursday, May 16, 2024SOU EXTENSION 2 GRANTED

Related Keywords

therapeutics transcode preparations medical purposes diagnostic cancer treatment pharmaceutical